XPO-1 inhibitors
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for XPO-1 inhibitors, covering 2023-02-09 to 2023-02-09. Get the full timeline:
Most recent: Clinical Trial Update: Clinical Study of XPO-1 Inhibitors Plus CAR-T Cells in Relapsed Refractory B-cell Non-Hodgkin's Lymphoma [Phase 2]